Inicio>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Bometolol Hydrochloride

Bometolol Hydrochloride

Catalog No.GC32665

El clorhidrato de bometolol es un agente bloqueador beta-adrenérgico, utilizado para la investigaciÓn de enfermedades cardiovasculares.

Products are for research use only. Not for human use. We do not sell to patients.

Bometolol Hydrochloride Chemical Structure

Cas No.: 65023-16-7

Tamaño Precio Disponibilidad Cantidad
1mg
2.115,00 $
Disponible
5mg
5.295,00 $
Disponible
10mg
9.000,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Bometolol Hydrochloride is a beta-adrenergic blocking agent, used for the research of cardiovascular disease.

Bometolol (10-30 mg/kg, p.o.) lowers the blood pressure dose-dependently in spontaneously hypertensive rats, deoxycorticosterone and salt hypertensive rats and two kindey, one clip hypertensive rats. In subchronic study, Bometolol (10-30 mg/kg, or 100-300 mg/kg, p.o.) dose-dependently decreases heart rate, plasma renin activity, heart and kindey weitht and incidence of vascular lesion, but shows no antihypertensive effects in all the hypertensive rats[1].

[1]. Watanabe TX, et al. Acute and subchronic effects of bometolol on blood pressure in hypertensive rats. J Pharmacobiodyn. 1981 Jul;4(7):505-12.

Reseñas

Review for Bometolol Hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Bometolol Hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.